| Endometrial Adenocarcinoma studied in …STUDIED_INderived120 of 120show fewer |
|---|
| → studied in | NCT03348631Phase 2 · active not recruiting Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05256225Phase 3 · recruiting Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | Endometrial Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07705035Phase 1 · recruiting DBC-664 in Adult Patients With Solid Tumors · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05112601Phase 2 · recruiting Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07078838Phase 2 · not yet recruiting Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer · condition mapped ALIAS · 120 trials mapped (51 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03643510Phase 2 · completed Evaluating Cancer Response to Treatment With Abemaciclib and Fulvestrant in Women With Recurrent Endometrial Cancer · condition mapped ALIAS · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04604613active not recruiting Prediction of Recurrence Among Low Risk Endometrial Cancer Patients · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02397083Phase 2 · active not recruiting Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07812636early Phase 1 · not yet recruiting Tirzepatide and Levonorgestrel IUD Therapy for EIN and Early-Stage Endometrial Cancer · condition mapped ALIAS · 120 trials mapped (51 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00977574Phase 2 · active not recruiting Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02208375Phase 1 · active not recruiting mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05950464Phase 1 · recruiting Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02142803Phase 1 · active not recruiting TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | Endometrial Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03660826Phase 2 · active not recruiting Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07349641Phase 2 · not yet recruiting A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05548296Phase 2 · recruiting A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06792552Phase 1 · recruiting A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors · condition mapped ALIAS · 120 trials mapped (51 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05231122Phase 2 · recruiting Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06399757Phase 1/Phase 2 · active not recruiting A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03914612Phase 3 · active not recruiting Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05538897Phase 1/Phase 2 · active not recruiting Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03586661Phase 1 · completed Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03120624Phase 1 · active not recruiting VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04092270Phase 1 · active not recruiting A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | Endometrial High Grade Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06476808Phase 1 · recruiting A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors. · condition mapped ALIAS · 120 trials mapped (51 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04719273Phase 2 · completed Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04214067Phase 3 · active not recruiting Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07436793Phase 2 · recruiting Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07675967recruiting Clonal Hematopoiesis Chemotherapy and Radiation Effects Study · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06213571NA · completed Remote Home-Based Exercise Program for Strength Training in Endometrial Cancer Survivors in Rural Areas · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06967961NA · recruiting Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers · condition mapped ALIAS · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04494113early Phase 1 · active not recruiting Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of Hysterectomy · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07107334Phase 2 · recruiting A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia · condition mapped ALIAS · 120 trials mapped (51 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03008408Phase 2 · active not recruiting A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07583329not yet recruiting Comparison of Sentinel Lymph Node Applications in Endometrial Cancer Cases Performed With Vaginal Natural Orifice Transluminal Endoscopic Surgery (V-NOTES) and Conventional Laparoscopy · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05049538recruiting Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | Endometrial Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01737619NA · active not recruiting PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | Endometrial Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02874430Phase 2 · terminated Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | Endometrial Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07062016recruiting Molecular and ctDNA Characterization of High-Risk Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | Endometrial High Grade Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05870761Phase 2 · active not recruiting Combination Niraparib and Dostarlimab Therapy for Recurrent or Persistent Uterine Serous Carcinoma · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04814108Phase 2 · completed A Study of Azenosertib (ZN-c3) in Women With Recurrent or Persistent Uterine Serous Carcinoma · condition mapped ALIAS · 120 trials mapped (51 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05824481Phase 2 · active not recruiting Study of Cadonilimab (AK104) Plus Lenvatinib in Patients With Advanced Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06369155Phase 2 · recruiting Azenosertib in Uterine Serous Carcinoma: Biomarker Study · condition mapped ALIAS · 120 trials mapped (51 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06689956recruiting Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07226102NA · withdrawn Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic or Breast Cancer · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05542407Phase 1 · recruiting ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03422198Phase 3 · recruiting Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | Endometrial Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05902988Phase 1/Phase 2 · recruiting A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer · condition mapped ALIAS · 120 trials mapped (51 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03325634Phase 1 · completed Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Primary Ovarian or Uterine Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04049227early Phase 1 · completed Abemaciclib and Letrozole in Treating Patients With Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04106414Phase 2 · active not recruiting Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03460483NA · completed Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01935934Phase 2 · completed Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | Endometrial Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06861855not yet recruiting Prognosis of METTL-14 in Endometrial Carcinoma · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03300557Phase 2 · completed Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04080284Phase 2 · completed Trial of Maintenance With Niraparib- Uterine Serous Carcinoma · condition mapped ALIAS · 120 trials mapped (51 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07077876recruiting Surgical and Obstetric Outcomes in Endometrial Adenocarcinoma and Atypical Endometrial Hyperplasia With Conservative Treatment · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07028242not yet recruiting Ultrasound and Histology in AEH and Early EEC Treated Conservatively · condition mapped ALIAS · 120 trials mapped (51 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06917092Phase 2 · recruiting QL1706-Based Therapy Post-PD-1/L1 Failure in Advanced Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02684227Phase 2 · completed Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03552471Phase 1 · completed Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04906382early Phase 1 · terminated Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06677242not yet recruiting Serous Endometrial Intraepithelial Carcinoma (SEIC): Prospective Registration Study · condition mapped ALIAS · 120 trials mapped (51 active) | — | — | Serous Endometrial Intraepithelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05655260NA · recruiting PErsonalized TReatment for Endometrial Carcinoma · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06278857Phase 2 · recruiting SATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr) · condition mapped ALIAS · 120 trials mapped (51 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03677024NA · withdrawn Evaluation of the Efficacy for Sentinel Lymph Node Policy in Intermediate-risk Endometrial Carcinomas · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01686126Phase 2 · active not recruiting Improving the Treatment for Women With Early Stage Cancer of the Uterus · condition mapped ALIAS · 120 trials mapped (51 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01344837completed Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05001282Phase 1/Phase 2 · terminated A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02020707Phase 1 · completed Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | Endometrial Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02501954Phase 3 · completed Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed Radiation Then Further Carbo and Taxol · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | Endometrial Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04972682NA · completed [SENTRY] Tailoring Postoperative Management Through Sentinel Lymph Node Biopsy in Low- and Intermediate-Risk Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05390021NA · withdrawn PET/MRI in Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | Endometrial Mixed Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06066216Phase 2 · not yet recruiting Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01041027Phase 2 · terminated Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05498597Phase 1 · unknown AMT-151 in Patients With Selected Advanced Solid Tumours · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02112552Phase 2 · terminated Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04590248Phase 2 · completed A Study of Adavosertib as Treatment for Uterine Serous Carcinoma · condition mapped ALIAS · 120 trials mapped (51 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02059265Phase 2 · terminated Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | Endometrial Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00492778Phase 2 · unknown Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04873206completed Diagnostic and Prognostic Value of PTEN Expression in Functional and Pathological Endometrial Biopsies · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02549209Phase 2 · completed Pembro/Carbo/Taxol in Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03221400Phase 1/Phase 2 · unknown PEN-866 in Patients With Advanced Solid Malignancies · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02728258Phase 2 · completed Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01307631Phase 2 · completed Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02315469completed Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03018249early Phase 1 · completed Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00942357Phase 3 · unknown Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | Endometrial Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02065687Phase 2/Phase 3 · unknown Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00285415Phase 2 · terminated A Phase II Evaluation of Docetaxel and Carboplatin Followed by Tumor Volume Directed Pelvic Irradiation · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01935973Phase 1 · completed Trametinib With or Without GSK2141795 in Treating Patients With Recurrent or Persistent Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03716414completed Evaluation of the Efficacy for Sentinel Lymph Node Policy in High-risk Endometrial Carcinoma · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00478426Phase 2 · completed Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01870947NA · completed Assisted Exercise in Obese Endometrial Cancer Patients · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03540407Phase 2 · completed Evaluation of Oncoxin-Viusid® in Cervical Cancer and Endometrial Adenocarcinoma. · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01132820Phase 2 · completed Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006089Phase 2 · completed Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00095979Phase 2 · completed Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01011933Phase 2 · completed Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03836157Phase 2 · withdrawn Mirvetuximab Soravtansine (IMGN853) and Bevacizumab in Patients With Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00807768Phase 3 · unknown Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | Endometrial Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01010126Phase 2 · completed Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01440998Phase 1 · completed Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01005329Phase 2 · completed Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01642082Phase 2 · completed Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01210222Phase 2 · completed Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00820898Phase 2 · completed Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00888173Phase 2 · completed Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01225887Phase 2 · completed Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00575952Phase 1 · completed Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | Endometrial Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01208467completed Prognostic Biomarkers in Patients With Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00064025Phase 2 · completed Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002706Phase 3 · completed Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006011Phase 3 · completed Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00072176Phase 2 · completed Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005830Phase 1 · completed Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005840Phase 1 · completed Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 120 trials mapped (51 active) | — | — | Endometrial Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00814086Phase 1 · completed Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01943058Phase 2 · withdrawn Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025467Phase 2 · completed Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer · condition mapped CURATED_BROADER · 120 trials mapped (51 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |